ELOSITY Trademark

Trademark Overview

On Friday, December 9, 2022, a trademark application was filed for ELOSITY with the United States Patent and Trademark Office. The USPTO has given the ELOSITY trademark a serial number of 97980427. The federal status of this trademark filing is SU - NON-FINAL ACTION - MAILED as of Friday, September 26, 2025. This trademark is owned by Labcorp Endpoint Clinical Inc.. The ELOSITY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing online non-downloadable software for managing trial sites, inventory of clinical trial supplies, studies, randomization of clinical trial participants, supply chain, drug supplies, reporting, and electronic data reconciliation in connection with clinical trials; providing online non-downloadable software for collecting, storing, processing, managing, and reporting on clinical trial data
elosity

General Information

Serial Number97980427
Word MarkELOSITY
Filing DateFriday, December 9, 2022
Status807 - SU - NON-FINAL ACTION - MAILED
Status DateFriday, September 26, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 19, 2024

Trademark Statements

Description of MarkThe mark consists of the term "ELOSITY" in lower-case stylized font with a geometric design of a crown above the letter "I".
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesProviding online non-downloadable software for managing trial sites, inventory of clinical trial supplies, studies, randomization of clinical trial participants, supply chain, drug supplies, reporting, and electronic data reconciliation in connection with clinical trials; providing online non-downloadable software for collecting, storing, processing, managing, and reporting on clinical trial data

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, January 7, 2023
Primary Code042
First Use Anywhere DateSunday, March 9, 2025
First Use In Commerce DateSunday, March 9, 2025

Trademark Owner History

Party NameENDPOINT CLINICAL L.P.
Party Type21 - New Owner After Publication
Legal Entity Type13 - Limited Partnership
AddressRALEIGH, NC 27617
Party NameENDPOINT CLINICAL INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDURHAM, NC 27709
Party NameENDPOINT CLINICAL INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressDURHAM, NC 27709
Party NameLabcorp Endpoint Clinical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWakefield, MA 01880

Trademark Events

Event DateEvent Description
Tuesday, December 13, 2022NEW APPLICATION ENTERED
Tuesday, January 10, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, September 18, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, January 7, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 14, 2023ASSIGNED TO EXAMINER
Monday, September 18, 2023NON-FINAL ACTION WRITTEN
Monday, September 18, 2023NON-FINAL ACTION E-MAILED
Friday, December 8, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 14, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 14, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 8, 2024FINAL REFUSAL WRITTEN
Monday, January 8, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, January 8, 2024FINAL REFUSAL E-MAILED
Wednesday, November 8, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, December 8, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 8, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 14, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 23, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 23, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, February 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 28, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 19, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 19, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 6, 2024SOU EXTENSION 1 FILED
Wednesday, November 6, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, November 26, 2024SOU EXTENSION 1 GRANTED
Tuesday, November 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 26, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 2, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 2, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 2, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, December 2, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 6, 2024SOU TEAS EXTENSION RECEIVED
Monday, December 2, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 8, 2025DIVISIONAL REQUEST RECEIVED
Tuesday, April 8, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, April 8, 2025TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, April 8, 2025TEAS STATEMENT OF USE RECEIVED
Wednesday, September 3, 2025SOU EXTENSION 2 GRANTED
Wednesday, September 3, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 3, 2025DIVISIONAL PROCESSING COMPLETE
Tuesday, April 8, 2025SOU EXTENSION 2 FILED
Tuesday, April 8, 2025USE AMENDMENT FILED
Wednesday, September 3, 2025STATEMENT OF USE PROCESSING COMPLETE
Monday, September 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 26, 2025SU - NON-FINAL ACTION - WRITTEN
Friday, September 26, 2025NON-FINAL ACTION E-MAILED
Friday, September 26, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

elosity trial clinical providing data reporting downloadable supplies online managing software